Estimate Recalculated Mar 20, 2025 08:36PM EST
Jason Amello has an estimated net worth of $2.54 Million. This is based on reported shares across multiple companies, which include TScan Therapeutics, Inc., GENZYME CORP, ZIOPHARM ONCOLOGY INC, Akebia Therapeutics, Inc., Acer Therapeutics Inc., and Candel Therapeutics, Inc..
Jason Amello's CIK is 0001451805
2022 was Jason Amello's most active year for acquiring shares with 5 total transactions. Jason Amello's most active month to acquire stocks was the month of January. 2011 was Jason Amello's most active year for disposing of shares, totalling 13 transactions. Jason Amello's most active month to dispose stocks was the month of March. 2017 saw Jason Amello paying a total of $481,650.00 for 86,500 shares, this is the most they've acquired in one year. In 2011 Jason Amello cashed out on 65,364 shares for a total of $3,512,819.70, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!